ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626868 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626868; 2) Community: the network communities that were significantly associated with the response to NSC 626868; 3) Molecule: the relationships between components within communities and NSC 626868; 4) MDR: the compounds that were significantly associated with the NSC 626868.

NSC Compound Enrichment Correlation
NSC 672868 Null 0.0392716453377535 0.18233933
NSC 673499 Null 0.0392716453377535 0.36819506
NSC 681972 Null 0.0392716453377535 0.27673138
NSC 684409 18-Norestr-4-en-3-one, 17-ethynyl-13-ethyl- 17.beta.-hydroxy-,2-[(9,10-dihydro-10-oxo-4-acridinyl)carbonyl]hydrazone 0.0392716453377535 0.13350137
NSC 684906 Null 0.0392716453377535 0.33247184
NSC 701022 Null 0.0392716453377535 0.13823511
NSC 701102 2H-1-Benzopyran-2-one, 6-chloro-3-[6-chloroimidazo[1,2-a]pyridin-2-yl]- 0.0392716453377535 0.22234329
NSC 718781 Erlotinib hydrochloride 0.0392716453377535 -0.24986792
NSC 733149 Null 0.0392716453377535 0.12237251
NSC 748147 5-methyl-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide 0.0392716453377535 0.13824158
Total:52  Current:44    [First] [Prev] [Next] [Last]